About Smith & Nephew plc (LON:SN)
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.
Industry, Sector and Symbol:
- Industry: Medical Devices & Implants
- Sub-Industry: N/A
- Sector: Medical Devices & Implants
- Symbol: LON:SN
- CUSIP: N/A
- Web: www.smith-nephew.com
- Trailing EPS: GBX 0.74
- Net Margins: 13.87%
- Return on Equity: 15.84%
- Return on Assets: 8.74%
- Outstanding Shares: 891,150,000
Frequently Asked Questions for Smith & Nephew plc (LON:SN)
What is Smith & Nephew plc's stock symbol?
Smith & Nephew plc trades on the London Stock Exchange (LON) under the ticker symbol "SN."
How often does Smith & Nephew plc pay dividends? What is the dividend yield for Smith & Nephew plc?
Smith & Nephew plc announced a dividend on Thursday, July 27th. Investors of record on Thursday, October 5th will be given a dividend of GBX 0.12 per share on Wednesday, November 1st. This represents a yield of 0.72%. The ex-dividend date of this dividend is Thursday, October 5th. The official announcement can be accessed at this link. View Smith & Nephew plc's Dividend History.
Where is Smith & Nephew plc's stock going? Where will Smith & Nephew plc's stock price be in 2017?
10 equities research analysts have issued 1 year target prices for Smith & Nephew plc's shares. Their predictions range from GBX 1,144 to GBX 1,515. On average, they expect Smith & Nephew plc's share price to reach GBX 1,315.40 in the next twelve months. View Analyst Ratings for Smith & Nephew plc.
Who are some of Smith & Nephew plc's key competitors?
Some companies that are related to Smith & Nephew plc include Smith & Nephew SNATS (SNN), Glaukos Corporation (GKOS), Endologix (ELGX), Cerus Corporation (CERS), RTI Surgical (RTIX), OrthoPediatrics Corp. (KIDS), ConforMIS (CFMS), Obalon Therptcs (OBLN), Trivascular Technologies (TRIV), Second Sight Medical Products (EYES), Uroplasty (UPI), Concepta PLC (CPT), China Kanghui Holdings (KH), Cyberonics (CYBX), HeartWare International (HTWR) and St Jude Medical (STJ).
Who are Smith & Nephew plc's key executives?
Smith & Nephew plc's management team includes the folowing people:
- Olivier Bohuon, Chief Executive Officer, Executive Director (Age 58)
- Graham Baker, Chief Financial Officer, Executive Director (Age 48)
- Rodrigo Bianchi, President, Asia Pacific and Emerging Markets (Age 57)
- Brad Cannon, President, Europe and Canada (Age 49)
- Vasant Padmanabhan Ph.D., President - Research & Development (Age 50)
- Cyrille Petit, Chief Corporate Development Officer, President - Global Business Services (Age 46)
- Matthew R. Stober, President - Global Operations (Age 49)
- Glenn S. Warner, President, US (Age 54)
- Elga Lohler, Chief Human Resource Officer (Age 49)
- John W. Campo, Chief Legal Officer (Age 62)
How do I buy Smith & Nephew plc stock?
Shares of Smith & Nephew plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Smith & Nephew plc's stock price today?
One share of Smith & Nephew plc stock can currently be purchased for approximately GBX 1,329.56.
How big of a company is Smith & Nephew plc?
Smith & Nephew plc has a market capitalization of £11.61 billion.
How can I contact Smith & Nephew plc?
Smith & Nephew plc's mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The company can be reached via phone at +44-20-74017646.
MarketBeat Community Rating for Smith & Nephew plc (LON SN)MarketBeat's community ratings are surveys of what our community members think about Smith & Nephew plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Smith & Nephew plc (LON:SN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 7 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings|
|Consensus Rating:||Hold (Score: 2.10)|
|Consensus Price Target: ||GBX 1,315.40|
Consensus Price Target History for Smith & Nephew plc (LON:SN)
Analysts' Ratings History for Smith & Nephew plc (LON:SN)
(Data available from 11/17/2015 forward)
|11/3/2017||Berenberg Bank||Reiterated Rating||Hold||GBX 1,340 -> GBX 1,340|
|11/13/2017||J P Morgan Chase & Co||Lower Price Target||Neutral||GBX 1,382 -> GBX 1,369|
|11/6/2017||Jefferies Group LLC||Reiterated Rating||Buy||GBX 1,515|
|10/23/2017||Deutsche Bank AG||Boost Price Target||Hold||GBX 1,200 -> GBX 1,315|
|10/12/2017||Citigroup Inc.||Reiterated Rating||Sell||GBX 1,160|
|9/11/2017||Goldman Sachs Group, Inc. (The)||Reiterated Rating||Neutral||GBX 1,380|
|7/28/2017||Credit Suisse Group||Reiterated Rating||Neutral||GBX 1,280|
|5/15/2017||Morgan Stanley||Reiterated Rating||Overweight|
|5/5/2017||Numis Securities Ltd||Reiterated Rating||Add||GBX 1,350|
|5/5/2017||Shore Capital||Reiterated Rating||Hold||GBX 1,144|
|8/10/2016||Barclays PLC||Downgrade||Equal weight||GBX 1,230 -> GBX 1,240|
|8/9/2016||Beaufort Securities||Reiterated Rating||Hold|
|7/29/2016||BNP Paribas||Reiterated Rating||Outperform||GBX 1,425|
|3/17/2016||Nomura||Initiated Coverage||Neutral||GBX 1,215|
|3/10/2016||AlphaValue||Reiterated Rating||Add||GBX 1,389|
|2/9/2016||Sanford C. Bernstein||Reiterated Rating||Outperform||GBX 1,340|
Earnings History for Smith & Nephew plc (LON:SN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Smith & Nephew plc (LON:SN)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for Smith & Nephew plc (LON SN)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Smith & Nephew plc (LON SN)
Insider Trades by Quarter for Smith & Nephew plc (LON SN)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/16/2017||Virginia Bottomley||Insider||Buy||223||GBX 1,380||£3,077.40|
|3/9/2017||Olivier Bohuon||Insider||Sell||6,273||GBX 1,233||£77,346.09|
|3/7/2017||Olivier Bohuon||Insider||Sell||8,031||GBX 1,222||£98,138.82|
|8/15/2016||Bottomley ,Virginia||Insider||Buy||238||GBX 1,290||£3,070.20|
|5/11/2016||Bottomley ,Virginia||Insider||Buy||8||GBX 1,158||GBX 9,264|
|8/14/2015||Barlow ,Ian||Insider||Buy||153||GBX 1,188||£1,817.64|
|5/13/2015||Vinita Bali||Insider||Buy||2,400||GBX 1,118||£26,832|
|3/9/2015||Julie Brown||Insider||Sell||4,227||GBX 1,128.79||£47,713.95|
|2/5/2015||Julie Brown||Insider||Sell||11,789||GBX 1,181||£139,228.09|
Headline Trends for Smith & Nephew plc (LON:SN)
Latest Headlines for Smith & Nephew plc (LON SN)
Financials are not available for this stock.
Smith & Nephew plc (LON SN) Chart for Friday, November, 17, 2017